Year-to-date money raised in public, private and other financings of biopharma companies.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Amneal, Formycon, Invivyd, Mannkind, Novo Nordisk, Reviva, Samsung Bioepis, Regeneron, Sanofi, Zai Lab.

Biopharma happenings, including deals and partnerships, and other news in brief: Bioeq, Cassava, Dexcel, GSK, Orexo, Samsung Biologics, Seismic, Vaccinex, Windtree, Zydus.

Clinical updates, including data readouts and publications: Agenus, Biogen, Dogwood, Hope Biosciences, Neurocrine.

New hires and promotions in the biopharma industry, including: Avicanna, Dyne.

New hires and promotions in the med-tech industry, including: Henry Schein.

Med-tech firms raising money in public or private financings, including: Nanalysis Scientific, Picard Medical, Sequana Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acera, Next Gen, Pure Genetic, Pure Medical, Seastar, Singlera, Solventum.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bruno Vision, Crescom.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Abbisko, Altamira, Astrazeneca, Boehringer, Cytokinetics, Daiichi Sankyo, Gensight, Hansa, Huonslab, Incyte, Kalvista, Merck & Co., Merck KGaA, PTC, Roche, Savara, Viridian.